As the Society is pleased with this announcement, we understand the shortage continues to be crucial at many sites throughout the country and desire the FDA to make sure that once supplies are available, hematologists can have information on how to gain access to this therapy for their critically ill patients. ASH has been working hard to handle the shortage, including reporting shortages to the FDA and Congress and urging the FDA to take immediate action to recognize other manufacturers to meet demand, import supplies from overseas, and establish a crisis supply once there is a release in order that supplies can be conveniently accessed. Related StoriesResearchers determine new way to greatly help AML sufferers avoid a relapseTSRI experts find way to improve leukemia cells into leukemia-killing immune cellsScientists engineer stem cells to better understand mechanisms behind leukemiaOver days gone by year the Culture has led collaborative attempts with the FDA, Congress, and senior wellness officials in the Administration to resolve not only this shortage, but also shortages greater than 200 other drugs, many of which are accustomed to treat patients with hematologic diseases, which have become essential and life-threatening.The AMSBIO range includes professional antibodies, peptides and recombinant proteins. Furthermore the company can attract upon in-depth expertise in extracellular matrices to provide elegant solutions for learning cell motility, migration, invasion and proliferation. Widely acknowledged as professionals in cell culture, AMSBIO partners with customers in tailoring cell systems to improve screening outcomes and eventual prognosis. With a variety of molecular detection reagents, and a substantial Biorepository the company may also provide tissue DNA, RNA, microarray and protein products. Key analysis areas for the products consist of: Oncology, Regenerative Medicine, Environmental Analysis, Cytotoxicity Screening, Glycomics and Stem Cell Biology.

Addition of two MRI sequences to MRPA improves recognition of pulmonary embolism New research implies that the addition of two magnetic resonance imaging sequences to a common MR angiography technique significantly improves detection of pulmonary embolism, a potentially life-threatening condition traditionally diagnosed through computed tomography .